In vitro neuroprotective properties of the novel cholinergic channel activator (ChCA), ABT-418

Brain Research

Volumn 719, Issue 1-2, 1996, Pages 36-44

  Donnelly Roberts, Diana L ^a   Xue, Iris C ^a   Arneric, Stephen P ^a   Sullivan, James P ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

ABT 418; Calcium channel activator; Cholinergic channel activator; Glutamate; Neuronal acetylcholine receptor; Neuroprotection

Indexed keywords

3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; GLUTAMIC ACID; LACTATE DEHYDROGENASE; NEUROPROTECTIVE AGENT; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; BRAIN CORTEX; CALCIUM TRANSPORT; CELL CULTURE; CONTROLLED STUDY; FETUS; GLIA CELL; NERVE CELL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029899143     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00063-7     Document Type: Article

References (51)

1. Akaike, A., Tamura, Y., Yokota, T., Shimohama, S. and Kimura, J., Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity, Brain Res., 644 (1994) 181-187.
2. Arneric, S. P., Sullivan, J.P., Briggs, C.A., Donnelly-Roberts, D., Anderson, D.J., Raszkiewicz, J.L., Hughes, M., Cadman, E.D., Adams, P., Garvey, D.S., Wasiacak, J. and Williams, M., ABT-418: a novel cholinergic channel ligand with cognition enhancing and anxiolytic activity: I. In vitro characterization, J. Pharmacol. Exp. Ther., 270 (1994) 310-318.
3. Arneric, S.P., Sullivan, J.P. and Williams. M., Neuronal nicotinic receptors. Novel targets for CNS therapeutics. In F.E. Bloom and D.J. Kupfer (Eds.), Psychopharmacology: the Fourth Generation of Progress, Raven Press, New York, 1995, pp. 94-110.
4. Arneric, S. P., Anderson, D.A., Bannon, A.W., Briggs, C.A., Buccafusco, J.J., Brioni, J.D., Decker, M.W., Donnelly-Roberts, D., Gopalakrishnan, M., Holladay, M.W., Kyncl, J., Marsh, K.C., Pauly, J., Radek, R.J., Rodrigues, A.D. and Sullivan, J.P., Preclinical pharmacology of ABT-418: a prototypical cholinergic channel activator for the potential treatment of Alzheimer's disease, CNS Drug Rev., 1 (1995) 1-26.
5. Badio, B. and Daly, J.W., Epibatidine, a potent analgetic and nicotinic agonist, Mol. Pharmacol., 45 (1994) 563-569.
6. Bertrand, D., Bertrand. S. and Ballivet, M., Pharmacological properties of the homomeric α7 receptor, Neurosci. Lett., 146 (1992) 87-90.
7. Betrand, D., Galzi, J.L., Devillers-Thiery, A., Betrand, S. and Changeux, J.P., Mutations at two distinct sites within the channel domain M2 alter calcium permeability of neuronal α7 nicotinic receptor, Proc. Natl. Acad. Sci. USA, 90 (1993) 6971-6975.
8. Briggs, C.A., McKenna, D.G. and Piatonni-Kaplan, M., Human α7 nicotinic acetycholine receptor responses to novel ligands, Neuropharmacology, 34 (1995) 583-590.
9. Brioni, J.D., O'Neill, A., Kim, D.J.B., Decker, M.W. and Arneric, S.P., Anxiolytic-like effects of the novel cholinergic channel activator, ABT-418, J. Pharamcol. Exp. Ther., 271 (1994) 353-361.
10. Castro, N.G. and Albuquerque, E.X., α-Bungarotoxin-sensitive hippocampal nicotinic receptor channel has a high calcium permeabil-ity, Biophys. J., 68 (1995) 516-524.
11. Choi, D.W., Maulucci-Gedde M.A. and Kreigstein, A.R., Glutamate neurotoxicity in cortical cell culture, J. Neurosci., 7 (1987) 357-368.
12. Cooper, E., Couturier, S. and Ballivet, M., Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor, Nature, 350 (1991) 235-238.
13. Couturier, S., Bertrand, D., Matter, J.-M., Hernadez, M.-C., Bertrand, S., Millar, N., Valera, S., Barkas, T. and Ballivet, M., A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homo-oliomeric channel blocked by α-BTX, Neuron, 5 (1990) 847.
14. Decker, M.W., Brioni, J.D., Sullivan, J.P., Buckley, M., Radek, R., Raszkiewicz, J.L., Hughes, M., Giardina, W., Williams, M., Arneric, S.P., ABT-418: a novel cholinergic ligand with cognition enhancing and anxiolytic activities: II. In vivo characterization, J. Pharmacol. Exp. Ther., 270 (1994) 319-328.
15. Deneris, E.S., Connolly, J., Rogers, S.W. and Duvoisin, R., Pharmcological and functional diversity of neuronal nicotinic acetylcholine receptors. Trends Pharmacol. Sci., 12 (1991) 34-40.
16. Doucette-Stamm, L., Monteggia, L.M., Donnelly-Roberts, D., Wang, M.T., Lee, J., Tian, J. and Giordano, T., Cloning and sequence of the human α7 nicotinic acetylcholine receptor, Drug Dev. Res., 30 (1993) 252-256.
17. Elgoyhen, A.B., Johnson, D.S., Boulter, J., Vetter, D.E. and Heinemann, S.F., α9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell, 79 (1994) 705-715.
18. Flores, C.M., Rogers, S.W., Pabreza, L.A., Wolfe, B.B. and Kellar, K.J., A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment, Mol. Pharmacol., 41 (1991) 31-37.
19. Franklin, J.L. and Johnson, Jr., E.M., Suppression of programmed neuronal death by sustained elevation of cytoplasmic calcium, Trends Neurosci., 15 (1992) 501-508.
20. Freedman, R., Wetmore, C., Stromberg, I., Leonard, S. and Olson, L., α-Bungarotoxin binding to hippocampal interneurons: immunocytochemical characterization and effects on growth factor expression, J. Neurosci., 13 (1993) 1965-1975.
21. Garvey, D.S., Wasiack, J.T., Decker, M.W., Brioni, J.D., Buckley, M.J., Sullivan, J.P., Garrera, G.M., Holladay, M.H., Arneric, S.P. and Williams, M., Novel isoxazoles which interact with brain cholinergic channel receptors have intrinsic cognitive enhancing and anxiolytic activities, J. Med. Chem., 37 (1994) 1055-1059.
22. Gerzanich, V., Anand, R. and Linstrom, J., Homomers of α8 and α9 subunits of nicotinic recepotrs exhibit similar channel but contrasting binding site properties, Mol. Pharmacol., 45 (1994) 212-220.
23. Ghosh, A. and Greenberg, M.E., Calcium signaling in neurons: molecular mechanisms and cellular consequences, Science, 268 (1995) 239-247.
24. Gopalakrishnan, M., Buisson, B., Touma, E., Giordano, T., Campbell, J.E., Hu, I.C., Donnelly-Roberts, D., Arneric, S.P., Bertrand, D. and Sullivan, J.P., Stable expression and pharmacological properties of the human α7 nicotinic acetylcholine receptor, Eur. J. Pharmacol., 290 (1995) 237-246.
25. Gopalakrishnan, M.G., Monteggia, L.M., Anderson, D.A., Molinari, E.J., Piatonni-Kaplan, M., Donnelly-Roberts, D., Arneric, S.P. and Sullivan, J.P., Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine α4β2 receptor, J. Pharmacol. Exp. Ther. (1995) in press.
26. Greenberg, M.E., Ziff, E.B. and Greene, L.A., Stimulation of neuronal acetylcholine receptors induces rapid gene transcription, Science, 234 (1986) 80-83.
27. Koh, J.Y. and Choi, D.W., Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay, J. Neurosci. Methods, 20 (1987) 83-90.
28. Leutje, C.W. and Patrick, J., Both alpha and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptor, J. Neurosci., 11 (1991) 837-845.
29. Lukas, R.J., Expression of ganglia-type nicotinic acetylcholine receptors and nicotinic ligand binding sites by cells of the IMR-32 human neuroblastoma clonal cell line, J. Pharmacol. Exp. Ther., 265 (1993) 294-302.
30. Marin, P., Maus, M., Desagher, S., Glowinski, J., Premont, J., Nicotine protects cultured striatal neurones against N-methyl-D-aspartate receptor-mediated neurotoxicity, Neuroreport, 5 (1994) 1977-1980.
31. Martin, E.J., Panickar, K.S., King, M.A., Deyrup, M., Hunter, B.E., Wang, G. and Meyer, E.M., Neuroprotective actions of 2,4-dimethoxybenzylidene anabaseine in differentiated PC12 cells and septal cholinergic neurons, Drug. Dev. Res., 31 (1994) 135-141.
32. McGehee, D.S., Heath, M.J.S., Gelber, S., Devay, P., and Role, L.W. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors, Science, 269 (1995) 1692-1696.
33. Meldrum, B. and Garthwaite, J., Excitatory amino acid neurotoxicity and neurodegenerative disease, Trends Pharmacol. Sci., 11 (1990) 379-387.
34. Newhouse, P., Sunderland, T., Tariot, P., Blumhardt, C.L., Weingartner, H. and Mellow, A., Intravenous nicotine in Alzheimer's disease: a pilot study, Psychopharmacology, 95 (1988) 171-175.
35. Nitsch, R.M., Farber, S.A., Growdon, J.H. and Wurtman, R.J., Release of amyloid β-protein precursor derivatives by electrical depolarization of rat hippocampal slices, Proc. Natl. Acad. Sci. USA, 90 (1993) 5191-5193.
36. Oppenheim, R.W., Yin, Q.W., Prevette, D. and Yan, Q., Brain-derived neurotrophic factor resues developing avian motoneurons from cell death, Nature, 360 (1992) 755-757.
37. Owman, C., Fuxe, K., Jason, A.M. and Kahrstrom, J., Studies of protective actions of nicotine on neuronal and vascular functions in the brain of rats: comparison between sympathetic noradrenergic and mesostriatal doapminergic fiber system, and the effects of a dopamine agonist, Prog. Brain Res., 79 (1989) 267-276.
38. Peng, X., Katz, M., Gerzanich, V., Anand, R. and Lindstrom, J., Human α7 receptor: cloning of the α7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional α7 homomers expressed in Xenopus oocytes, Mol. Pharmacol., 45 (1994) 546-554.
39. Prehn, J.H., Bindokas, V.P., Marcuccilli, C.J., Krajewski, S., Reed, J.C. and Miller, RJ., Regulation of neuronal Bcl2 protein expression and calcium homeostasis by transforming growth factor type ß confers wide-ranging protection on rat hippocampal neurons, Proc. Natl. Acad. Sci. USA, 91 (1994) 12599-12603.
40. Puchacz, E., Buisson, B., Bertrand, D. and Lukas, R., Functional expression of nicotinic acetylcholine receptors containing rat α7. subunits in human SH-SY5Y neuroblastoma cells, FEBS Lett., 354 (1994) 155-159.
41. Rathouz, M.M. and Berg, D.K., Synaptic-type acetylcholine receptors raise intracellular calcium levels in neurons by two mechanisms. J. Neurosci., 14 (1994) 6935-6945.
42. Sands, S.B., Costa, A.C.S. and Patrick, J.W., Barium permeability of neuronal nicotinic receptor α7 expressed in Xenopus oocytes, Biophys. J., 65 (1993) 2614-2621.
43. Sargent, P.B., The diveristy of neuronal nicotinic acetylcholine receptor, Ann. NY Acad. Neurosci., 16 (1993) 403-443.
44. Seguela, P., Wadiache, J., Dineley-Miller, K., Dani, J.A. and Patrick, J.W., Molecular cloning, functional properties, and distribution of rat brain alpha7: a nicotinic cation channel highly permeable to calcium, J. Neurosci., 13 (1993) 596-604.
45. Shearman, M. S., Ragan, C.I. and Iversen, L.L., Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death, Proc. Natl. Acad. Sci. USA, 91 (1994) 1470-1474.
46. Smith, C.J. and Giacobini, E., Nicotine, Parkinson's and Alzheimer's disease, Rev. Neurosci., 3 (1992) 25-42.
47. Sullivan, J.P., Decker, M.W., Brioni, J.D., Donnelly-Roberts, D., Anderson, D.A., Bannon, A.W., Kang, C.-H., Adams, P.A., Piatonni-Kaplan, M., Buckley, M.J., Gopalakrishnan, M., Williams, M. and Arneric, S.P., (±)-Epibatidine elicits a diveristy of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors, J. Pharmacol. Exp. Ther., 271 (1994) 324-331.
48. Treinin, M. and Chalfie, M., A mutated acetylcholine receptor subunit causes neuronal degeneration in C. elegans, Neuron, 14 (1995) 871-877.
49. 2+, Neuron, 8 (1992) 353.
50. Whiting, P., Schoepfer, R., Lindstrom, J. and Priestley, T., Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts, Mol. Pharmacol., 40 (1991) 463-472.
51. Wonnacott, S., Irons, J., Rapier, C., Thorne, B. and Lunt, G.G., Presynsaptic modulation of transmitter release by nicotinic receptors. In A. Nordberg, K. Fuxe, B. Holmstedt and A. Sundwall (Eds.), Progress in Brain Research, Elsevier, Amsterdam, 1990, pp. 157-163.